top of page

biologit MLM-AI
Literature Monitoring for Biotechs

Unexpected Safety Findings are Costly

Adverse events hidden in the literature can derail the approval of promising compounds, cause inspection findings, re-work and submission failures. Protect your investment with compliant and efficient literature processes powered by biologit MLM-AI. Get in touch for a demo and free trial.

Find every adverse event from the literature

Get to inspection-ready literature process

Eliminate risks from regulatory submissions

Liberate specialists for high value work

pharma ukraine icon

Pharma, Ukraine

ʽʽ We are glad to use the biologit MLM-AI platform in our routine pharmacovigilance activities. Thank you for your product that makes our job easier. ʼʼ 

biotech service provider

Service Provider for Biotechs

ʽʽThe platform has made our lives easier. Most of the manual work is reduced, be it retrieving the hits, emailing articles, or a duplicate check.ʼʼ

us service provider icon

US Service Provider for Top 50 Pharma

ʽʽSince implementing biologit, we noticed a considerable improvement in our overall quality. The special situation tags, in particular, have proven beneficial in accurately identifying cases involving pediatric patients for off-label usage of medications.ʼʼ

Complete Solution for Compliant Regulatory Searches

biologit MLM-AI is a complete pharmacovigilance literature monitoring platform built for biotechs. Meet all FDA and EMA regulatory literature requirements faster, with high quality and from a modern interface the entire team can collaborate. Leverage our unique AI technology fine tuned for pharmacovigilance that delivers up to 70% workflow savings.

signal detection

Configurable and compliant screening workflows from clinical development to post-marketing.

productivity gains

AI-powered workflows built for safety surveillance delivering up to 70% productivity gains.

customer support

Easy to setup and get started, with extensive documentation, first-class customer support and online tutorials.

Download our White Paper​

We explore the challenges, trends and opportunities offered by new technologies to deliver efficient and compliant literature processes, and how those challenges can be met today with biologit MLM-AI platform.

download white paper

Global and Local Literature Out of the Box

Break free from expensive licenses for literature databases. The global and regional coverage of the biologit Database​ is available out of the box for all your

regulatory search requirements.

Over 55 million citations, 110,000 journals and 130+ countries, updated daily, including PubMed, Crossref, DOAJ, and a growing list of regional databases.


Compliant, Validated and Audit-Ready

biologit MLM-AI is a validated platform built following best industry practices and ready for your regulatory needs: our feature set aligns with GVP-VI guidelines for medical literature monitoring, and role-based user management and audit trail features to ensure CFR-11 compliance.

audit trial

Permanent audit trail of all screening decisions and system activity.

role based

Configurable role-based permissions for teams of all sizes.

validated settings

Validated, Cloud-based solution running on secure data centres (EU).

Get started with biologit MLM-AI  today 👉

bottom of page